Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
1300
¥ million (expected)Wording
Avoiding a definitive answer
How definitive the wording is.Expected Recognition of an Extraordinary Gain from the Sale of Investment Securities
Subject Entity
Achilles Corporation (the Company)
Target Locations / Products
5 listed securities held by the Company
Occurrence7 August 2026 (sale resolved by the Board of Directors)
This disclosure08/07/2026
Cause
To reduce cross-shareholdings and improve capital efficiency
Amount of Impact on Business Performance
Approximately ¥1,300 million (expected extraordinary gain)
Accounting period in which recognized
Fiscal year ending March 2027
Impact on Earnings Forecast
Already incorporated into the full-year consolidated earnings forecast for the fiscal year ending March 2027
Outlook
The Company expects to sell the investment securities between 10 August and 30 September 2026 and recognize the gain on sale as an extraordinary gain in the fiscal year ending March 2027.
| Item | Details |
|---|---|
| Event name | Expected Recognition of an Extraordinary Gain from the Sale of Investment Securities |
| Date of occurrence | 7 August 2026 (sale resolved by the Board of Directors) |
| Subject Entity | Achilles Corporation (the Company) |
| Target Locations / Products | 5 listed securities held by the Company |
| Cause | To reduce cross-shareholdings and improve capital efficiency |
| Amount of Impact on Business Performance | Approximately ¥1,300 million (expected extraordinary gain) |
| Accounting period in which recognized | Fiscal year ending March 2027 |
| Impact on Earnings Forecast | Already incorporated into the full-year consolidated earnings forecast for the fiscal year ending March 2027 |
| Outlook | The Company expects to sell the investment securities between 10 August and 30 September 2026 and recognize the gain on sale as an extraordinary gain in the fiscal year ending March 2027. |
Items this document does not state (16)
Date recognized / date notice receivedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To reduce cross-shareholdings and improve capital efficiency.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.